Purchase Order 75D30124P19808
Award Date
9/3/24
Potential Completion Date
9/30/24
Potential Value
$257K
Federal Agency
CDC Pittsburgh
Awardee
Element Biosciences, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Element Biosciences, Inc., a small disadvantaged business based in San Diego, California. The contract is for the procurement of the AVITI System, a next-generation DNA sequencing platform, and associated sequencing kits and services. The contract has a ceiling value of $295,000.00 and a period of performance that extends through April 22, 2025. The contract does not utilize a...
The federal contract award with ID 75D30124P19758 was made by the Centers for Disease Control and Prevention (CDC) to Element Biosciences, Inc., a manufacturer of genetic analysis equipment and tools. The $115,000.00 firm fixed price purchase order is for the provision of lab equipment and services. The contract has an ultimate completion date of September 22, 2029. No small business set-aside was utilized. Element Biosciences, Inc. has previously received other federal contracts from the U.S....
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Illumina, Inc., a manufacturer of genetic and genomic analysis equipment and reagents. The $197,052.50 firm fixed price purchase order is for the delivery of lab equipment, with a performance period ending on August 31, 2027. Illumina has previously received prime contracts and subcontracts from various federal agencies, including the NIH, CDC, USDA, and VA, to...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for reagents to be used with Illumina's sequencing systems. The $219,192.00 contract does not have a set-aside designation and is intended to support the CDC's needs through August 31, 2022. Illumina has a history of providing sequencing equipment, consumables, and services to...
This is a firm fixed price contract award to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents, by the Centers for Disease Control and Prevention (CDC) for laboratory equipment. The contract has a ceiling value of $232,307.62 and a completion date of October 24, 2016. It is a Blanket Purchase Agreement (BPA) call, which suggests it is part of a larger contracting vehicle. Illumina has a history of providing sequencing systems, reagents, and bioinformatics...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the provision of Genomic Sequencing Kits with a ceiling value of $170,641.14 and a performance period ending on August 28, 2024. The contract does not utilize a set-aside designation. Illumina is the prime contractor and has been awarded multiple federal contracts...
This is a firm fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $236,726.60 contract is for a service agreement to provide the CDC with Illumina's advanced sequencing instruments, reagents, consumables, and bioinformatics software. The contract does not have a set-aside designation and has an ultimate completion date of August 31, 2026....
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions, for the provision of lab supplies. The $16,168.00 contract has an April 29, 2024 completion date and was awarded on August 22, 2019. The lab supplies are to be delivered to the CDC's location in Atlanta, GA. Illumina is a for-profit organization and manufacturer that has previously...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $85,056.40 contract is for the delivery of laboratory reagents, with an ultimate completion date of July 31, 2022. The contract does not have a set-aside designation. Illumina has previously received federal prime contract and subcontract awards from agencies like the National...